Efficacy And Tolerability Of Ixazomib, Daratumumab And Low Dose Dexamethasone (Ixa Dara Dex) In Unfit And Frail Newly Diagnosed Multiple Myeloma (Ndmm) Patients; Results Of The Interim Efficacy Analysis Of The Phase Ii Hovon 143 Study

BLOOD(2019)

引用 18|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要